4 Sources Hims & Hers Comms X February 7, 2026 FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs U.S
It is the same molecule marketed under brand names for diabetes and weight management, and it is also the compound most 503A pharmacies prepare for telehealth programs
It appears on active and certified finished and unfinished drugs submitted in structured product labeling (SPL) files, including prescription, over-the-counter (OTC), and certain compounded drug products, as noted by the FDA in 2026
Mecanismo de accin: Cmo funcionan estos frmacos
Meanwhile, undeterred by all this infighting, other pharmaceutical companies like Pfizer are still trying to enter the GLP-1 arena
Storage instructions are on the SDS card